press print

WeWork selects Houston as one of its markets for a 3D printing pilot program

Houston is one of only five WeWork Labs markets that can expect access to 3D printers as a part of a pilot program with two companies. Courtesy of WeWork

WeWork has teamed up with two leading 3D printing companies to bring their technology into five WeWork Labs markets — including Houston's downtown location. The other locations tapped for the pilot program are London, San Francisco, New York, and Seattle.

Massachusetts-based Formlabs' Form 2 printer has over 20 different material resins WeWork Labs members can use to prototype and print products using desktop stereolithography.

"Formlabs was founded eight years ago on the basis of empowering anyone to make anything," says Max Lobovsky, CEO and co-founder of Formlabs in a release. "Today, our customers have printed more than 40 million parts, they vary from early stage entrepreneurs changing the status quo and developing new applications to Fortune 500s experimenting with new business models or production methods."

The other company involved in the program is Seattle-based Glowforge, which created a 3D laser printer. Glowforge Plus uses subtractive laser technology to cut and sculpt projects from materials like wood, leather, acrylic, stone — and even stickers. The company, which was founded in 2014, has had over three million prints on its devices — everything from jewelry and clothing to machinery.

"We are thrilled to partner with WeWork Labs to provide their community of entrepreneurs and startups alike access to the tools that will help them create corporate giveaways, new product prototypes, and full production runs — everything to take their dreams from idea to creation," says Dan Shapiro, CEO of Glowforge, in the release.

The printers will be revealed at various launch events celebrating the National Week of Making, which begins June 21 and goes through June 27. Houston's launch event will be on June 28, but the specifics have not yet been finalized.

"We see WeWork Labs as a platform for creators, innovators and makers alike, and believe partnering with Glowforge and Formlabs will give our members even more of an opportunity to take their ideas, and bring them to life," says Katie Perkins, creative director at WeWork Labs, in the release. "We are incredibly excited to welcome two leading brands and their products into our community, giving creators access to the tools they need and inspiring new creators to be makers themselves."

Houston's WeWork Labs program launched in March in the WeWork Jones Building at 708 Main St. and includes a partnership with local digital startup resource, Alice. The WeWork Labs program started a little over a year ago and is already in over 30 markets worldwide.

"As the fourth largest city, Houston is in a unique position to launch high-impact startups," says Houston Labs Manager Carlos Estrada, in a previous release. "We see WeWork Labs in Houston as a tremendous platform for innovation, as our founder-focused approach to supporting early-stage startups will nurture and accelerate the work of entrepreneurs to scale their solutions to today's biggest challenges."

Form 2

Courtesy of WeWork

Using 20 types of resin materials, Formlabs' Form 2 can create parts or prototypes.

Trending News

Building Houston

 
 

You can now hop online and invest in this promising cell therapy startup. Photo via Getty Images

A clinical-stage company headquartered in Houston has opened an online funding campaign.

FibroBiologics, which is developing fibroblast cell-based therapeutics for chronic diseases, launched a campaign with equity crowdfunding platform StartEngine. The platform lets anyone — regardless of their net worth or income level — to invest in securities issued by startups.

The funding, according to a press release, will be used to support ongoing operations of Fibrobiologics and advance its clinical programs in multiple sclerosis, degenerative disc disease, wound care, extension of life, and cancer.

"We're excited to partner with StartEngine on this campaign. StartEngine has over 600,000 investors as part of their community and has raised over half a billion dollars for its clients," says FibroBiologics' Founder and CEO Pete O'Heeron, in the release.

"This is an exciting time at FibroBiologics as we continue progressing our clinical pipeline and developing innovative therapies to treat chronic diseases," he continues. "This new funding will fuel our growth in the lab and bring us one step closer to commercialization."

The campaign, launched this week, already has over 100 investors, at the time of publication, and has raised nearly $2 million, according to the page. The minimum investment is set at around $500, and the company's indicated valuation is $252.57 million.

In 2021, FibroBiologics announced its intention of going public. Last year, O'Heeron told InnovationMap on the Houston Innovators Podcast of the company's growth plans as well as the specifics of the technology.

Only two types of cells — stem cells and fibroblasts — can be used in cell therapy for a regenerative treatment, which is when specialists take healthy cells from a patient and inject them into a part of the body that needs it the most. As O'Heeron explains in the podcast, fibroblasts can do it more effectively and cheaper than stem cells.

"(Fibroblasts) can essentially do everything a stem cell can do, only they can do it better," says O'Heeron. "We've done tests in the lab and we've seen them outperform stem cells by a low of 50 percent to a high of about 220 percent on different disease paths."


Trending News